Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Pfizer CEO Albert Bourla wants to tap 'Chinese science' as the drug company looks for a new target after COVID

Bourla hopes to bring the same speed in developing a COVID vaccine to discovering new cancer treatments.

Fortune · Oct 12, 2023

Modern companies need a purpose. Execs share advice

“It’s so incredibly powerful [to] have a very clear sense of your objectives.” Angela Hwang, Pfizer’s chief commercial officer said during a MPW panel.

Fortune · Oct 11, 2023

Minneapolis Radio Station Trolls Taylor Swift, Travis Kelce With Billboard Before Chiefs-Vikings

Minnesota knew what audience to tailor to, no pun intended.

Sports Illustrated · Oct 8, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Chiefs’ Travis Kelce Responds to Aaron Rodgers’s ‘Mr. Pfizer’ Jab

“Who knew I’d get into the vax wars with Aaron Rodgers, man?”

Sports Illustrated · Oct 6, 2023

Updated COVID-19 shot slowly rolls out in Texas, but access is spotty

Doses aren’t arriving at providers’ offices at uniform, predictable intervals. Shipments are largely dependent on individual providers’ ability to work out the logistics of ordering, stocking, training and paperwork.

The Texas Tribune · Oct 5, 2023

Travis Kelce’s Rumored Romance With Taylor Swift Boosts Brand Engagement

Pfizer and Campbell Soup see surge in searches and sales after dating rumors

Zenger · Oct 5, 2023

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

StockNews.com · Oct 5, 2023

Read news from The Economist, FT, and more,
with one subscription

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Salon · Oct 5, 2023

3 Quality Stocks to Defend Your Portfolio Against October Volatility

The sell-off in the U.S. stock market has deepened in October, and the Dow Jones Industrial Average is now negative for the year. Amid a challenging macro environment, Berkshire Hathaway, Pfizer, and Coca-Cola look like three good defensive stocks to buy.

Barchart · Oct 4, 2023

US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

The Independent UK · Oct 3, 2023

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Hindu · Oct 3, 2023

Tenacious curiosity in the lab can lead to a Nobel Prize – mRNA research exemplifies the unpredictable value of basic scientific research

The 2023 Nobel Prize in physiology or medicine will go to Katalin Karikó and Drew Weissman for their discovery that modifying mRNA – a form of genetic material your body uses to produce proteins – could reduce unwanted inflammatory responses and allow it to be delivered into cells. While the…

The Conversation · Oct 3, 2023

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Independent UK · Oct 2, 2023

Nobel prize in medicine awarded to mRNA pioneers – here's how their discovery was integral to COVID vaccine development

Billions of people around the world have received the Pfizer or Moderna COVID-19 vaccines. The rapid development of these vaccines changed the course of the pandemic, providing protection against the SARS-CoV-2 virus.

The Conversation · Oct 2, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu · Oct 2, 2023

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

The Independent UK · Sep 28, 2023

What to know as fall vaccinations against COVID, flu and RSV get underway

Fall vaccination season is in full swing, with health officials urging both an updated COVID-19 shot and flu vaccine for most everyone

Barchart · Sep 28, 2023

Is Pfizer Stock a Buy Near 52-Week Lows for Its 5.08% Yield?

Pfizer stock faces a steep patent cliff, but it's taken steps to offset the coming pressures. Will it be enough?

Salon · Sep 28, 2023

Hiccups reported in COVID vax rollout

New shots for COVID and RSV are available, if people can actually get them, let alone want them

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Sep 28, 2023

3 Recession-Proof Stocks to Buy Now

Some recent economic data points have revived recession fears, sending equities sharply lower this September. Here are 3 recession-proof stocks that conservative investors can consider now.

The Independent UK · Sep 25, 2023

Tornado-damaged Pfizer plant in North Carolina restarts production

A major Pfizer pharmaceutical plant has restarted production, 10 weeks after it was heavily damaged by a tornado

Barchart · Sep 25, 2023

2 Undervalued Dividend Stocks with 5% Yields To Buy Near 52-Week Lows

Shares of Pfizer and Citigroup are languishing near their 52-week lows. However, both stocks offer dividend yields in excess of 5%, and investors might want to buy these two undervalued income plays at current levels.

WEKU · Sep 22, 2023

CDC recommends RSV vaccine in late pregnancy to protect newborns

The shot will help shield newborns from RSV in the early months of life, when they're especially vulnerable to severe illness.

The Independent UK · Sep 22, 2023

RSV vaccine recommended during pregnancy as a second option to protect newborns

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns

StockNews.com · Sep 22, 2023

Pfizer Inc. (PFE) – Buy or Hold Analysis on This Pharma Stock

Leading pharma company Pfizer (PFE) is struggling to recover from waning Covid vaccine demand and is eyeing cost-cutting measures. So, is the stock worth buying? Read on.

The Independent UK · Sep 21, 2023

Booking a COVID-19 vaccine? Some are reporting canceled appointments or insurance issues

Pfizer and Moderna say they have sent out millions of doses of the new COVID-19 vaccines in the past week

1 … 22 23 24 25

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The Kansas City Chiefs

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.